MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
Information source: Milton S. Hershey Medical Center
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Contraceptive Use; Unintended Pregnancy
Intervention: Reproductive Life Planning (RLP) (Behavioral); Contraceptive Action Planning (Behavioral); Contraception information (Behavioral)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Milton S. Hershey Medical Center Official(s) and/or principal investigator(s): Cynthia H Chuang, MD, MSc, Principal Investigator, Affiliation: Penn State College of Medicine
Summary
The purpose of this web-based study is to determine whether reproductive life planning
(RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of
unintended pregnancy when compared to an information-only control group.
Clinical Details
Official title: Reducing Unintended Pregnancies Through Reproductive Life Planning and Contraceptive Action Planning
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Primary outcome: contraceptive use
Secondary outcome: effectiveness of contraceptive methodcontraceptive method satisfaction contraceptive self-efficacy continuity of contraceptive use contraceptive adherence
Detailed description:
Most US families want 2 children, resulting in the average woman spending 3 decades of her
life trying to avoid pregnancy. However, most women have at least one unintended pregnancy,
resulting in 1. 5 million abortions and 1. 7 million unintended births annually. Women and
couples try to avoid unintended pregnancy for a range of personal, social, and economic
reasons, but also due to the increased physical and mental health effects for children that
result from unintended pregnancy. Healthcare reform now requires that private health
insurance companies cover all FDA-approved contraceptive methods with no copays or
deductibles to the patient, creating a great opportunity for women with health insurance to
get contraceptive methods they previously could not afford. In this study, women with health
insurance will be randomly assigned to one of three groups: (1) Reproductive Life Planning
(RLP)—women will complete a reproductive life plan that guides them to think about if and
when they would want any future pregnancies, and to determine what contraceptive method(s)
are best suited to them; (2) Reproductive Life Planning Plus (RLP+) which additionally
includes "if-then planning," where women determine what they will do when they encounter
difficult situations that make it difficult to use their contraceptive method perfectly; or
(3) an information-only control group. The online format of the study allows for the
potential of wide dissemination. The RLP and RLP+ interventions are expected to result in
greater likelihood of contraceptive use, continuity of contraceptive use, and contraceptive
adherence, and thus reduce overall risk of unintended pregnancy.
Eligibility
Minimum age: 18 Years.
Maximum age: 40 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- not currently pregnant
- sexually active with a male partner in the past 6 months OR anticipate being sexually
active with a male partner in the next 6 months
- does not intend pregnancy in the next 12 months
- has Internet access and email address
Exclusion Criteria:
- tubal sterilization
- hysterectomy
- partner with vasectomy
Locations and Contacts
Penn State College of Medicine, Hershey, Pennsylvania 17033, United States
Additional Information
Starting date: April 2014
Last updated: October 31, 2014
|